A randomized controlled trial of pulsed field ablation vs antiarrhythmic therapy as a first-line treatment for persistent atrial fibrillation: The AVANT GUARD trial rationale and design

By afschroeder • March 31, 2026

Wazni OM, Chun KJ, Amin A, Anic A, Ajijola OA, Gibson DN, Mansour M, Makati K, Chrispin J, Duytschaever M, Nair DG, Piccini JP, Natale A, Raciti G, Wehrenberg S, McCammon S, Albrecht EM, Garlitski A, Sutton BS, Andrade JG; AVANT GUARD Investigators. A randomized controlled trial of pulsed field ablation vs antiarrhythmic therapy as a first-line treatment for persistent atrial fibrillation: The AVANT GUARD trial rationale and design. Heart Rhythm O2. 2025 Dec 23;7(3):561-574. doi: 10.1016/j.hroo.2025.12.011. PMID: 41908201; PMCID: PMC13031045.

Tags: antiarrhythmic drugs, Cardiology/Epi, catheter ablation, First-line therapy, persistent atrial fibrillation, Publications, pulsed field ablation, Randomized Controlled Trial

Median Survival Among Patients Hospitalized for Heart Failure with Reduced Ejection Fraction Prescribed Quadruple Medical Therapy

Greene SJ, Xu H, Chiswell K, Felker GM, Lewsey SC, Divanji PH, Goertz HP, Heitner SB, Butler J, Fonarow GC. Median Survival Among Patients Hospitalized[...]

Adult congenital cardiac interventional training, competencies, and organization. A Statement of the ESC ACHD Working Group, the EAPCI, the AEPC, and the PICS-Society

Chessa M, Brida M, Budts W, Chieffo A, Dua J, Kaleschke G, Kempny A, Kenny D, Krasemann T, Rahbek Schmidt M, Aboulhosn J. Adult congenital[...]

Comprehensive macroscopic living anatomy of the swine heart: comparative visual approach with virtual dissection

Rios KP, Moussa AM, Rios HA, Rimmer M, Miyazaki Y, Aoyama D, Aladham RN, Defelice LG, Hanna P, Hayase JH, Chung WH, Xu S, Ajijola[...]